Zhang et al. (2026) discovered that α-eleostearic acid and its methyl ester act as novel senolytic agents by inducing ferroptosis in senescent cells, achieving over 80% clearance with minimal toxicit...
Recent research identifies specific senescent cell types linked to diabetes and hypertension, enabling personalized therapies and AI-driven predictive health tools for aging populations. New studies m...
Personalized nutrition leverages AI and genomic data to create tailored diets, improving metabolic health and reducing chronic diseases, as shown in recent studies and FDA approvals. AI-driven persona...
Advances in AI and genomics are tailoring diets to individual needs, improving metabolic health and reducing disease risks like obesity and diabetes through data-driven insights. Personalized nutritio...
Recent studies reveal specific gut bacteria strains like Faecalibacterium prausnitzii and Lactobacillus rhamnosus GG improve mental health and metabolic regulation, prompting calls for personalized pr...
New research reveals prenatal PFAS exposure disrupts maternal beta cell function, increasing diabetes risk, with significant socioeconomic disparities in exposure levels. Recent studies show prenatal ...
Recent studies highlight curcumin’s potential in managing diabetes and hypertension, with new formulations enhancing bioavailability and clinical efficacy. New research reveals curcumin’s ...
New research shows prenatal PFAS exposure disrupts maternal beta cell function, increasing gestational diabetes risk by 30%, with long-term metabolic consequences. Emerging evidence reveals PFAS chemi...
Recent research shows prenatal PFAS exposure disrupts maternal beta cell function, increasing diabetes risk years after pregnancy, with significant public health implications. Groundbreaking study rev...
Emerging research links PFAS exposure to increased diabetes risk through beta cell dysfunction, highlighting urgent policy and lifestyle interventions. New studies reveal how ‘forever chemicals&...
